In a sterile lab in San Jose, a 34-year-old software engineer named Marcus Webb is learning to type with his mind. Not metaphorically. A 64-electrode array implanted in his motor cortex translates neural firing patterns into keystrokes at 62 words per minute — faster than most people type with their hands.
The Race to the Brain
Neuralink's N1 chip has been implanted in 23 patients. Synchron's Stentrode has FDA breakthrough designation. BrainGate, Precision Neuroscience, Paradromics — the field has exploded from academic curiosity to venture-backed arms race in under a decade.
We are not building a product. We are building a new relationship between human cognition and digital infrastructure.
The Consent Problem
The deeper issue isn't technical. It's philosophical. When a device can read your intentions before you act on them, who owns that data? When your employer can theoretically measure your cognitive engagement in real time, what happens to the concept of mental privacy?
"The question is no longer whether we can merge with machines. It's whether we should — and who gets to decide."
What Comes Next
The regulatory landscape is scrambling to catch up. The FDA's current framework for neural devices was written for passive implants — pacemakers, cochlear implants. It has no vocabulary for devices that learn, adapt, and potentially influence the very cognition they're monitoring.
